DKSH has entered a partnership with Aurobindo Pharma Limited to bring necessary medication, including antibiotic, antihypertensive, and respiratory treatment, to patients in Cambodia. DKSH Cambodia will support Aurobindo Pharma in expanding the business, strengthening brand presence, and increasing market share.
Cambodia, Phnom Penh, February 14, 2025 - DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an agreement with Aurobindo Pharma Ltd, an integrated global pharmaceutical company providing a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients, in Cambodia. As part of the partnership, DKSH will expand Aurobindo Pharma’s products, including anti-biotic, antihypertensive, and respiratory medicines to the Cambodian market.
DKSH Cambodia’s experienced teams and broad distribution network will ensure that Aurobindo Phar-ma’s products reach modern and traditional trade, hospitals, clinics, other medical channels, and pa-tients in need nationwide.
Philip Wray, Vice President of Healthcare at DKSH Cambodia, said: “We are delighted to be Aurobindo Pharma’s trusted and strategic partner. Through this partnership, we will provide high-quality antibiotics, antihypertensive, and respiratory medicines from a world-renowned pharmaceutical leader, aimed at enhancing patient outcomes across the Cambodian market. This collaboration underscores our commitment to improving health and quality of life for patients, in alignment with DKSH’s purpose of enriching people’s lives and our mission of providing healthcare for all.”.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited (www.aurobindo.com), (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. www.aurobindo.com
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. www.dksh.com